MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can distinguish single-base mismatches across all sgRNA positions with near-zero ...
CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...
Both stocks are risky, but one is far less so. Investors seeking stocks with explosive growth potential should consider the ...
Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...
Scientists grew a microscopic fungus into a more efficient — and meat-like — edible protein by tweaking just two genes with ...
For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...
Los Angeles wildfires, a CRISPR milestone, and a de-extinction controversy are among 2025’s notable events captured in photos ...
The gene editing market is experiencing significant growth, with a projected annual growth rate (CAGR) of 16-18% in the coming years. This expansion is fueled by breakthroughs in gene-editing ...
To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...
But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this ...
Gene-edited crops are no safer than GMOs, and fast-tracking regulatory approval could trigger a costly backlash.
The CRISPR gene editing technique has had a dramatic influence on biomedical research, and has even been applied to a few ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback